Security key
004225108
ACADIA PHARMACEUTICALS INC - COMMON STOCK (ACAD)
CUSIP: 004225108
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 167,660,004
- Total 13F value
- $3,576,680,400
- Share change
- -2,080,268
- Put/Call ratio
- 75%
- SEC-reported price per share
- $21.34
- Number of holders
- 329
- Value change
- -$45,558,483
- Number of buys
- 180
- Number of sells
- 136
- Shares outstanding
- 171,249,283
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
329
Top holders
10
ACAD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
ACADIA PHARMACEUTICALS INC SEC filings
ACADIA PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 004225108
Recent filing periods:
Ownership snapshot
Top reported holders of ACAD - ACADIA PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
2/15
Latest evidence
30 Jun 2025
13F
13D/G
Lead comparable stake: 12%
13 rows are not safely comparable across share classes.
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 12%.
2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 2
BlackRock, Inc.
12%
RTW INVESTMENTS, LP
4.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
12%
Reported 13D/G
· 31 Jan 2025
|
$445,472,612
20,652,416 shares
|
— | 30 Jun 2025 |
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
4.2%
Reported 13D/G
· 30 Sep 2025
|
$194,033,949
8,995,547 shares
|
— | 30 Jun 2025 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$925,281,603
42,896,690 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$329,249,657
15,264,240 shares
|
— | 30 Jun 2025 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$133,260,409
6,178,044 shares
|
— | 30 Jun 2025 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$88,679,611
4,111,247 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
329
Shares
167,660,004
Rows available
329
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
308
Q3 2025 holders
329
Holder diff
21
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend